X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs AJANTA PHARMA - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD AJANTA PHARMA ORCHID PHARMA LTD/
AJANTA PHARMA
 
P/E (TTM) x 0.1 18.7 0.8% View Chart
P/BV x 0.2 7.5 2.3% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 ORCHID PHARMA LTD   AJANTA PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
AJANTA PHARMA
Mar-16
ORCHID PHARMA LTD/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1941,720 11.3%   
Low Rs351,103 3.2%   
Sales per share (Unadj.) Rs276.5194.6 142.1%  
Earnings per share (Unadj.) Rs-79.245.2 -175.2%  
Cash flow per share (Unadj.) Rs-43.550.3 -86.4%  
Dividends per share (Unadj.) Rs08.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs53.9132.0 40.9%  
Shares outstanding (eoy) m70.4588.77 79.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.47.3 5.7%   
Avg P/E ratio x-1.431.2 -4.6%  
P/CF ratio (eoy) x-2.628.1 -9.4%  
Price / Book Value ratio x2.110.7 19.9%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m8,067125,299 6.4%   
No. of employees `0002.8NA-   
Total wages/salary Rs m2,5272,570 98.3%   
Avg. sales/employee Rs Th6,956.1NM-  
Avg. wages/employee Rs Th902.5NM-  
Avg. net profit/employee Rs Th-1,993.0NM-  
INCOME DATA
Net Sales Rs m19,47717,275 112.7%  
Other income Rs m407166 244.9%   
Total revenues Rs m19,88417,442 114.0%   
Gross profit Rs m1,1035,807 19.0%  
Depreciation Rs m2,519451 559.1%   
Interest Rs m5,22749 10,688.8%   
Profit before tax Rs m-6,2365,474 -113.9%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-1251,460 -8.6%   
Profit after tax Rs m-5,5804,014 -139.0%  
Gross profit margin %5.733.6 16.8%  
Effective tax rate %2.026.7 7.5%   
Net profit margin %-28.723.2 -123.3%  
BALANCE SHEET DATA
Current assets Rs m11,0147,639 144.2%   
Current liabilities Rs m32,0602,715 1,181.0%   
Net working cap to sales %-108.128.5 -379.1%  
Current ratio x0.32.8 12.2%  
Inventory Days Days9543 219.5%  
Debtors Days Days3479 42.7%  
Net fixed assets Rs m29,4406,914 425.8%   
Share capital Rs m705177 398.2%   
"Free" reserves Rs m2,04311,442 17.9%   
Net worth Rs m3,80011,721 32.4%   
Long term debt Rs m9,018149 6,064.5%   
Total assets Rs m46,51014,814 314.0%  
Interest coverage x-0.2112.9 -0.2%   
Debt to equity ratio x2.40 18,705.6%  
Sales to assets ratio x0.41.2 35.9%   
Return on assets %-0.827.4 -2.8%  
Return on equity %-146.934.2 -428.8%  
Return on capital %-3.746.5 -8.0%  
Exports to sales %37.955.1 68.7%   
Imports to sales %22.66.0 376.6%   
Exports (fob) Rs m7,3789,527 77.4%   
Imports (cif) Rs m4,4061,038 424.6%   
Fx inflow Rs m7,51310,422 72.1%   
Fx outflow Rs m5,6491,678 336.6%   
Net fx Rs m1,8658,744 21.3%   
CASH FLOW
From Operations Rs m1,6823,264 51.5%  
From Investments Rs m-9,860-2,093 471.1%  
From Financial Activity Rs m6,644-1,186 -560.3%  
Net Cashflow Rs m-1,535-15 10,371.6%  

Share Holding

Indian Promoters % 32.3 73.8 43.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 1.6 296.8%  
FIIs % 3.3 7.6 43.4%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 17.0 325.3%  
Shareholders   84,811 20,968 404.5%  
Pledged promoter(s) holding % 54.9 4.4 1,251.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   MERCK LTD  STERLING BIOTECH  TORRENT PHARMA  ALEMBIC LTD  CIPLA  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


May 25, 2018 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - PFIZER COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS